CA2368007A1 - Composition pour une preparation a base d'un echantillon preleve sur un patient - Google Patents

Composition pour une preparation a base d'un echantillon preleve sur un patient Download PDF

Info

Publication number
CA2368007A1
CA2368007A1 CA002368007A CA2368007A CA2368007A1 CA 2368007 A1 CA2368007 A1 CA 2368007A1 CA 002368007 A CA002368007 A CA 002368007A CA 2368007 A CA2368007 A CA 2368007A CA 2368007 A1 CA2368007 A1 CA 2368007A1
Authority
CA
Canada
Prior art keywords
composition
amino
salt
mixtures
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002368007A
Other languages
English (en)
Inventor
Raymond Chan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2368007A1 publication Critical patent/CA2368007A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention porte sur une composition qui, ajoutée à un échantillon prélevé sur un patient et contenant un antigène cible dans un milieu de transport acide ou formolé, neutralise l'acide et le formol tout en préservant la réactivité immunologique de l'antigène permettant sa détection. Ladite composition comprend un tampon amino-glycolique, un acide aminé, un sel et un détergent non ionique. La présente invention porte également sur un procédé permettant de traiter un échantillon en y ajoutant une composition contenant un tampon amino-glycolique, un acide aminé, un sel et un détergent non ionique.
CA002368007A 1999-04-06 1999-04-06 Composition pour une preparation a base d'un echantillon preleve sur un patient Abandoned CA2368007A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/007573 WO2000060353A1 (fr) 1999-04-06 1999-04-06 Composition pour une preparation a base d'un echantillon preleve sur un patient

Publications (1)

Publication Number Publication Date
CA2368007A1 true CA2368007A1 (fr) 2000-10-12

Family

ID=22272513

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002368007A Abandoned CA2368007A1 (fr) 1999-04-06 1999-04-06 Composition pour une preparation a base d'un echantillon preleve sur un patient

Country Status (5)

Country Link
EP (1) EP1166111A1 (fr)
JP (1) JP2002541456A (fr)
AU (1) AU3475299A (fr)
CA (1) CA2368007A1 (fr)
WO (1) WO2000060353A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2655458A1 (fr) * 2006-06-19 2007-12-27 Becton, Dickinson And Company Procedes et compositions permettant d'obtenir des acides nucleiques amplifiables de tissus, cellules, ou virus exposes a des milieux de transport
DK2473596T3 (en) 2009-09-03 2018-01-22 Becton Dickinson Co METHODS AND COMPOSITIONS FOR DIRECT CHEMICAL LYSIS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185264A (en) * 1990-11-09 1993-02-09 Abbott Laboratories Diluent buffer and method for diluting an assay component
JPH06284886A (ja) * 1993-04-01 1994-10-11 Amano Pharmaceut Co Ltd 酵素の溶液中での安定化方法
US5695928A (en) * 1993-12-10 1997-12-09 Novartis Corporation Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
US5958300A (en) * 1998-02-06 1999-09-28 Genzyme Corporation Composition for patient sample preparation

Also Published As

Publication number Publication date
WO2000060353A1 (fr) 2000-10-12
JP2002541456A (ja) 2002-12-03
EP1166111A1 (fr) 2002-01-02
AU3475299A (en) 2000-10-23

Similar Documents

Publication Publication Date Title
Steinitz Quantitation of the blocking effect of tween 20 and bovine serum albumin in ELISA microwells
Smits et al. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus
JP3930519B2 (ja) イムノアッセイ用試薬の緩衝剤組成物
KR100771294B1 (ko) 폴리펩티드 및 항원 안정화 희석제
US4703001A (en) Immunoassay for the detection of serum analytes using pH dependent chastropic acids
JP2588274B2 (ja) 定性酵素アッセイの視覚的識別
KR100326619B1 (ko) 염기해리분석법
CA2360779A1 (fr) Dosage a fond reduit
EP0084531A1 (fr) Determination de virus par analyse.
JP2002535985A5 (fr)
DK155967C (da) Fremgangsmaade samt kit til bestemmelse af antistoffer mod oploeselige antigener
US20130130274A1 (en) Detection method
CN101446586A (zh) 免疫分析试剂和分析方法
US5958300A (en) Composition for patient sample preparation
CA2368007A1 (fr) Composition pour une preparation a base d'un echantillon preleve sur un patient
US5736348A (en) Method for the immunological diagnosis of Chagas' Disease using recombinant antigens
JPWO2018181263A1 (ja) 体液による抗原抗体反応阻害を防止する物質
Kenett A simple ELISA for the classification of monoclonal antibodies according to their recognition of native epitopes
JPH0531743B2 (fr)
US6703208B1 (en) Immunological assay for detection of antibodies in celiac disease
JP3034104B2 (ja) 金属イオンの錯化剤を含有する固相免疫検定法用洗浄溶液およびその使用
WO1988008136A1 (fr) Procede d'analyse permettant le diagnostic de l'infection du type chlamydia
Choy et al. A comparison of immunological methods for the detection of Trichinella spiralis antigen
AU1966201A (en) Immunological assay for detection of antibodies in celiac disease
WO1990002336A1 (fr) Analyse d'immunologie permettant de detecter la presence d'un antigene de type chlamydia, dans laquelle l'echantillon est traite au prealable avec un agent chelateur

Legal Events

Date Code Title Description
FZDE Discontinued